PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL)
CUSIP: 74019P207
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, par value $0.000005 per share
- Shares outstanding
- 24,241,780
- Total 13F shares
- 3,859,340
- Share change
- +549,044
- Total reported value
- $14,708,103
- Price per share
- $3.81
- Number of holders
- 51
- Value change
- -$4,075,765
- Number of buys
- 30
- Number of sells
- 18
Quarterly Holders Quick Answers
What is CUSIP 74019P207?
CUSIP 74019P207 identifies DTIL - PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74019P207:
Top shareholders of DTIL - PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.9%
|
702,069
|
$6,322,131 | — | 30 Sep 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.6%
|
623,332
|
$5,585,055 | — | 30 Sep 2024 | |
| NOVARTIS PHARMA AG |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
12,407,440
|
$4,590,753 | — | 15 Jun 2022 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.8%
|
426,293
|
$3,819,585 | — | 30 Sep 2024 | |
| Aquilo Capital Management, LLC |
13F
|
Company |
1.6%
|
381,803
|
$3,420,955 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
263,964
|
$2,365,117 | — | 30 Sep 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.73%
|
176,382
|
$1,580,383 | — | 30 Sep 2024 | |
| Derek Jantz |
3/4/5
|
Chief Scientific Officer, Director |
—
mixed-class rows
|
4,079,565
mixed-class rows
|
$1,509,439 | — | 07 Jun 2022 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.62%
|
150,180
|
$1,345,000 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.4%
|
97,275
|
$871,584 | — | 30 Sep 2024 | |
| Matthew R. Kane |
3/4/5
|
President and CEO, Director |
—
mixed-class rows
|
2,026,513
mixed-class rows
|
$749,324 | — | 07 Jun 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.33%
|
80,598
|
$722,158 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.27%
|
65,974
|
$591,189 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.23%
|
55,113
|
$493,812 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.15%
|
37,310
|
$334,298 | — | 30 Sep 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.14%
|
33,224
|
$298,000 | — | 30 Sep 2024 | |
| Moloney Securities Asset Management, LLC |
13F
|
Company |
0.13%
|
31,699
|
$284,023 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.12%
|
28,458
|
$254,984 | — | 30 Sep 2024 | |
| Tejara Capital Ltd |
13F
|
Company |
0.1%
|
24,358
|
$218,248 | — | 30 Sep 2024 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.09%
|
21,270
|
$190,579 | — | 30 Sep 2024 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
0.08%
|
20,220
|
$181,171 | — | 30 Sep 2024 | |
| Samuel C. Wadsworth |
3/4/5
|
Director |
—
mixed-class rows
|
14,028
mixed-class rows
|
$161,277 | — | 04 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.07%
|
16,306
|
$146,102 | — | 30 Sep 2024 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.06%
|
13,772
|
$123,397 | — | 30 Sep 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.05%
|
12,729
|
$114,052 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.05%
|
12,515
|
$112,134 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.05%
|
11,242
|
$100,728 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
10,534
|
$94,385 | — | 30 Sep 2024 | |
| Amundi |
13F
|
Individual |
0.04%
|
8,521
|
$77,967 | — | 30 Sep 2024 | |
| Alan List |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
5,469
mixed-class rows
|
$56,440 | — | 01 May 2024 | |
| Allworth Financial LP |
13F
|
Company |
0.02%
|
4,769
|
$42,731 | — | 30 Sep 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
0.02%
|
4,675
|
$41,888 | — | 30 Sep 2024 | |
| David S. Thomson |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
130,768
mixed-class rows
|
$41,260 | — | 23 Jun 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
2,870
|
$25,715 | — | 30 Sep 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
2,357
|
$21,119 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,883
|
$16,872 | — | 30 Sep 2024 | |
| Shane Barton |
3/4/5
|
VP & Corporate Controller |
—
mixed-class rows
|
33,562
mixed-class rows
|
$12,418 | — | 07 Jun 2023 | |
| Fayaz Khazi |
3/4/5
|
CEO of Elo Life Systems |
—
mixed-class rows
|
65,239
mixed-class rows
|
$8,880 | — | 07 Jun 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
469
|
$4,202 | — | 30 Sep 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
335
|
$3,002 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
275
|
$2,464 | — | 30 Sep 2024 | |
| Zurcher Kantonalbank (Zurich Cantonalbank) |
13F
|
Company |
0%
|
258
|
$2,312 | — | 30 Sep 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
152
|
$1,362 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
0%
|
125
|
$1,120 | — | 30 Sep 2024 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0%
|
118
|
$1,000 | — | 30 Sep 2024 | |
| SouthState Bank Corp |
13F
|
Company |
0%
|
95
|
$851 | — | 30 Sep 2024 | |
| Ameliora Wealth Management Ltd. |
13F
|
Company |
0%
|
33
|
$296 | — | 30 Sep 2024 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0%
|
22
|
$194 | — | 30 Sep 2024 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
12
|
$108 | — | 30 Sep 2024 | |
| MOTCO |
13F
|
Company |
0%
|
10
|
$90 | — | 30 Sep 2024 |
Institutional Holders of PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL) as of Q4 2024
As of 31 Dec 2024,
PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,859,340 shares.
The largest 10 holders included
Lynx1 Capital Management LP, TANG CAPITAL MANAGEMENT LLC, Aquilo Capital Management, LLC, GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Alyeska Investment Group, L.P., and Moloney Securities Asset Management, LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
50
Q4 2024 holders
51
Holder diff
1
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.